Neurotoxic Manifestations of an Overdose Intrathecal Injection of Gadopentetate Dimeglumine
نویسندگان
چکیده
منابع مشابه
Neurotoxic Manifestations of an Overdose Intrathecal Injection of Gadopentetate Dimeglumine
The intravenous administration of gadopentetate dimeglumine (GD) is relatively safe and rarely causes systemic toxicity in the course of routine imaging studies. However, the general safety of intrathecal GD has not been established. We report a very rare case of an overdose intrathecal GD injection presenting with neurotoxic manifestations, including a decreased level of consciousness, global ...
متن کاملMAGNEVIST (brand of gadopentetate dimeglumine) Injection FOR INTRAVENOUS ADMINISTRATION
Do not administer MAGNEVIST to patients with: o chronic, severe kidney disease (GFR < 30 mL/min/1.73m), or o acute kidney injury (see CONTRAINDICATIONS). Screen patients for acute kidney injury and other conditions that may reduce renal function. For patients at risk for chronically reduced renal function (for example, age >60 years, hypertension or diabetes), estimate the glomerular filtra...
متن کاملGadopentetate dimeglumine as an intradiscal contrast agent.
STUDY DESIGN Magnetic resonance discography using gadolinium as an intradiscal contrast agent was investigated in a prospective study. OBJECTIVE To evaluate the utility of magnetic resonance discography using gadolinium as an intradiscal contrast agent, as compared with the current standard of computed tomographic discography using intradiscal iodinated contrast agent. SUMMARY OF BACKGROUND...
متن کاملAnaphylactoid reactions to i.v. gadopentetate dimeglumine.
A 33-year-old obese woman was referred for MR because of progressive bi lateral loss of vision . Review of systems was negative for asthma, allergies, or previous drug sensitivities . Physical examination showed papilledema. Unenhanced sagittal T1-weighted and axial T2-weighted MR images obtained with a 1.5-T Phi lips system showed a communicating hydrocephalus with marked enlargement of the la...
متن کاملRapid bolus injection of gadopentetate dimeglumine: absence of side effects in normal volunteers.
The safety and tolerance of gadopentetate dimeglumine 0.1 mmol/kg when injected at a bolus rate (10 ml/15 sec; four times the recommended rate) was studied in 12 normal men between the ages of 20 and 36 years. Each of the subjects received a single injection of either gadopentetate dimeglumine (0.2 ml/kg) or a placebo (normal saline, 0.2 ml/kg), followed by a 7-day washout and a single injectio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Korean Medical Science
سال: 2010
ISSN: 1011-8934,1598-6357
DOI: 10.3346/jkms.2010.25.3.505